top of page
The Professional Network for Healthcare Experts
FDA Approves MSD’s Keytruda Combinations with Padcev for Muscle-Invasive Bladder Cancer
The approvals expand the use of Keytruda and Keytruda Qlex alongside Padcev into the perioperative treatment setting for adults with muscle-invasive bladder cancer.
nuaxia
Jul 134 min read
MSD Secures European Approval for Keytruda Combination Therapy in Ovarian Cancer
Keytruda now approved across EU for PD-L1-positive platinum-resistant ovarian, fallopian tube, and primary peritoneal carcinoma.
nuaxia
Apr 81 min read
bottom of page